Raymond James analyst James Rollyson raised the firm’s price target on NOV Inc. (NOV) to $19 from $18 and keeps an Outperform rating on the shares. NOV reported an across the board beat, ending the year in a solid position with a strong free cash flow performance, the analyst tells investors in a research note. Similar to others, the 2025 top line outlook is flattish, and Raymond James says NOV remains in the “prove it” stage of its new capital return program.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
